Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 18,803 | 17,949 | 15,539 | 14,157 | 8,980 |
| Cost of Goods | 10,328 | 9,831 | 8,498 | 7,710 | 4,230 |
| Gross Profit | 8,475 | 8,118 | 7,041 | 6,447 | 4,751 |
| Operating Expenses | 4,939 | 5,221 | 4,006 | 5,232 | 3,378 |
| Operating Income | 3,864 | 3,729 | 3,533 | 1,926 | 1,602 |
| Interest Expense | 251 | 217 | 122 | 130 | 119 |
| Other Income | -2,766 | -1,518 | -3,505 | -4,528 | -186 |
| Pre-tax Income | 848 | 1,993 | -94 | -2,733 | 1,297 |
| Income Tax | 232 | -1,333 | -801 | -17,667 | 155 |
| Net Income Continuous | 616 | 3,326 | 706 | 14,935 | 1,142 |
| Net Income | $616 | $3,326 | $706 | $14,935 | $1,142 |
| EPS Basic Total Ops | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| EBITDA(a) | $4,426 | $4,229 | $3,883 | $2,258 | $1,936 |